Figure 1.
ORR in the overall population and BTKi, number of prior therapy lines, and bendamustine subgroups. Best response rate (CR or PR) in the overall population (n = 455), and in prior BTKi (n = 393), no prior BTKi (n = 55), 1 to 2 prior therapy lines (n = 99), ≥3 prior therapy lines (n = 349), prior Benda (n = 244), and no prior Benda (n = 204) subgroups. Benda, bendamustine.

ORR in the overall population and BTKi, number of prior therapy lines, and bendamustine subgroups. Best response rate (CR or PR) in the overall population (n = 455), and in prior BTKi (n = 393), no prior BTKi (n = 55), 1 to 2 prior therapy lines (n = 99), ≥3 prior therapy lines (n = 349), prior Benda (n = 244), and no prior Benda (n = 204) subgroups. Benda, bendamustine.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal